1 Min Read
PARIS, June 18 (Reuters) - Cellectis SA : * Shares rise 50 percent after signs deal with Pfizer to develop
immunotherapy drugs in cancer
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.